Cargando…

Non-alcoholic Steatohepatitis Pathogenesis, Diagnosis, and Treatment

There has been a rise in the prevalence of non-alcohol fatty liver disease (NAFLD) due to the popularity of western diets and sedentary lifestyles. One quarter of NAFLD patients is diagnosed with non-alcoholic steatohepatitis (NASH), with histological evidence not only of fat accumulation in hepatoc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Bo, Chan, Siu-Lung, Li, Jack, Li, Kathryn, Wu, Hao, Cui, Kui, Chen, Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452937/ https://www.ncbi.nlm.nih.gov/pubmed/34557535 http://dx.doi.org/10.3389/fcvm.2021.742382

Ejemplares similares

Statins in Non-alcoholic Steatohepatitis
por: Torres-Peña, Jose D., et al.
Publicado: (2021)

The Role of Lipid Profile as an Independent Predictor of Non-alcoholic Steatosis and Steatohepatitis in Morbidly Obese Patients
por: Ganjooei, Narges Ashraf, et al.
Publicado: (2021)

Hypoxia-Inducible Factors as Key Players in the Pathogenesis of Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis
por: Holzner, Lorenz M. W., et al.
Publicado: (2021)

Diabetes and Its Cardiovascular Complications: Comprehensive Network and Systematic Analyses
por: Wu, Hao, et al.
Publicado: (2022)

Non-Alcoholic Steatohepatitis: Pathogenesis and Clinical Management
por: Salomone, Federico, et al.
Publicado: (2015)

Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis
por: Lee, Kuei-Chuan, et al.
Publicado: (2023)

Non-coding RNAs Regulate the Pathogenesis of Aortic Dissection
por: Hu, Yu-Yuan, et al.
Publicado: (2022)

Lipidomic identification of urinary extracellular vesicles for non-alcoholic steatohepatitis diagnosis
por: Zhu, Qingfu, et al.
Publicado: (2022)

A Novel Non-Invasive Approach Based on Serum Ceruloplasmin for Identifying Non-Alcoholic Steatohepatitis Patients in the Non-Diabetic Population
por: Wang, Qingling, et al.
Publicado: (2022)

The Association and Pathogenesis of SERPINA3 in Coronary Artery Disease
por: Li, Bo, et al.
Publicado: (2021)

Targeting acid ceramidase ameliorates fibrosis in mouse models of non-alcoholic steatohepatitis
por: Yu, Amy, et al.
Publicado: (2022)

Cellular senescence and abdominal aortic aneurysm: From pathogenesis to therapeutics
por: Wang, Ding, et al.
Publicado: (2022)

Developing a New qFIBS Model Assessing Histological Features in Pediatric Patients With Non-alcoholic Steatohepatitis
por: Liu, Feng, et al.
Publicado: (2022)

Extracellular vesicles as biomarkers and modulators of atherosclerosis pathogenesis
por: Patel, Sarvatit, et al.
Publicado: (2023)

Editorial: MINOCA: Pathogenesis, Diagnosis, Clinical Management and Evolution Towards Precision Medicine
por: D'Amario, Domenico, et al.
Publicado: (2022)

Association Between Non-alcoholic Fatty Liver Disease and Risk of Stroke: A Systematic Review and Meta-Analysis
por: Wang, Meng, et al.
Publicado: (2022)

Hypertension is prevalent in non-alcoholic fatty liver disease and increases all-cause and cardiovascular mortality
por: Ng, Cheng Han, et al.
Publicado: (2022)

Defective efferocytosis of vascular cells in heart disease
por: Singh, Bandana, et al.
Publicado: (2022)

Long Non-coding RNA: A Key Regulator in the Pathogenesis of Diabetic Cardiomyopathy
por: Guo, Yaoyao, et al.
Publicado: (2021)

Long non-coding RNAs in the pathogenesis of heart failure: A literature review
por: Fan, Xiaoyan, et al.
Publicado: (2022)

Cardiac sarcoidosis: a comprehensive review of risk factors, pathogenesis, diagnosis, clinical manifestations, and treatment strategies
por: Shah, Hussain Haider, et al.
Publicado: (2023)

Combined Serum Biomarkers in Non-Invasive Diagnosis of Non-Alcoholic Steatohepatitis
por: Yang, Mei, et al.
Publicado: (2015)

Limited applicability of cathepsin D for the diagnosis and monitoring of non‐alcoholic steatohepatitis
por: Kamarajah, Sivesh K, et al.
Publicado: (2019)

Endoplasmic Reticulum Stress and Pathogenesis of Vascular Calcification
por: Rao, Zhenqi, et al.
Publicado: (2022)

SPP1 and CXCL9 Promote Non-alcoholic Steatohepatitis Progression Based on Bioinformatics Analysis and Experimental Studies
por: Wang, Wen, et al.
Publicado: (2022)

Essential Genes and MiRNA–mRNA Network Contributing to the Pathogenesis of Idiopathic Pulmonary Arterial Hypertension
por: Hao, Shengyu, et al.
Publicado: (2021)

Hypertrophic Cardiomyopathy: From Phenotype and Pathogenesis to Treatment
por: Cheng, Zeyi, et al.
Publicado: (2021)

Impact of advanced liver fibrosis on atrial fibrillation recurrence after ablation in non-alcoholic fatty liver disease patients
por: Wang, Zhe, et al.
Publicado: (2022)

Role of Alcohol Metabolism in Non-Alcoholic Steatohepatitis
por: Baker, Susan S., et al.
Publicado: (2010)

Myeloid DLL4 Does Not Contribute to the Pathogenesis of Non-Alcoholic Steatohepatitis in Ldlr(-/-) Mice
por: Jeurissen, Mike L. J., et al.
Publicado: (2016)

Effects of treatment of non-alcoholic fatty liver disease on heart failure with preserved ejection fraction
por: Yang, Zifeng, et al.
Publicado: (2023)

Combined alcoholic and non-alcoholic steatohepatitis
por: Ntandja Wandji, Line Carolle, et al.
Publicado: (2020)

Association of mean arterial pressure with non-alcoholic fatty liver disease: results from the NAGALA study
por: Li, Xinghui, et al.
Publicado: (2023)

Ferroptosis and Autophagy-Related Genes in the Pathogenesis of Ischemic Cardiomyopathy
por: Zheng, Yue, et al.
Publicado: (2022)

Pathogenesis of pulmonary hypertension caused by left heart disease
por: Xiao, Mingzhu, et al.
Publicado: (2023)

Chronic Low-Dose Alcohol Consumption Promotes Cerebral Angiogenesis in Mice
por: Li, Jiyu, et al.
Publicado: (2021)

Editorial: Molecular and cellular mechanisms of heart failure: pathophysiology, pathogenesis and therapeutics
por: Lal, Sean, et al.
Publicado: (2023)

Fructose and Non-Alcoholic Steatohepatitis
por: Roeb, Elke, et al.
Publicado: (2021)

Advances in pathogenesis and treatment of essential hypertension
por: Ma, Jun, et al.
Publicado: (2022)

Use of GP73 in the diagnosis of non-alcoholic steatohepatitis and the staging of hepatic fibrosis
por: Li, Yadi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_j6ruaqaugqt3obfj4hlkru3jbh